摘要
肝癌是常见的恶性肿瘤之一。肝细胞癌(HCC)是最常见的病理分型,乙型肝炎病毒是HCC发展的最显著风险因素。晚期肝细胞癌易发生血管侵犯,以门静脉侵犯最为多见(PVTT),PVTT患者预后极差,死亡率极高。TACE广泛应用于中晚期肝细胞癌,目前有着大量的单独TACE或TACE联合其他方法治疗门静脉癌栓的文章。本文对肝细胞癌合并PVTT的TACE治疗进展作一综述。
Hepatocellular carcinoma (HCC) is one of the common malignancies. Hepatocellular carcinoma is the most common pathological strain, and hepatitis B virus is the most significant risk factor for HCC development. Advanced hepatocellular carcinoma is prone to vascular invasion, most commonly portal vein tumor thrombus (PVTT), and patients with PVTT have an extremely poor prognosis and high mortality rate. TACE is widely used in intermediate and advanced hepatocellular carcinoma, and there are numerous articles on TACE alone or TACE combined with other methods to treat por-tal vein thrombosis. This article reviews the progress of TACE treatment for hepatocellular carci-noma combined with PVTT.
出处
《临床医学进展》
2023年第2期1416-1420,共5页
Advances in Clinical Medicine
